Administration costs of intravenous biologic drugs for rheumatoid arthritis

BACKGROUND: Cost-effectiveness studies explicitly reporting infusion times, drug-specific administration costs for infusions or real-payer intravenous drug cost are few in number. Yet, administration costs for infusions are needed in the health economic evaluations assessing intravenously-administer...

Descripción completa

Detalles Bibliográficos
Autores principales: Soini, Erkki J, Leussu, Miina, Hallinen, Taru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825225/
https://www.ncbi.nlm.nih.gov/pubmed/24255834
http://dx.doi.org/10.1186/2193-1801-2-531

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825225/
https://www.ncbi.nlm.nih.gov/pubmed/24255834
http://dx.doi.org/10.1186/2193-1801-2-531

Ejemplares similares